Glipizide

Product NDC: 10544-193
11-digit product format: 105440193
Labeler code: 10544
Product ID: 10544-193_11f93c9c-792a-3add-e054-00144ff88e88
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Glipizide
Dosage form: TABLET
Route: ORAL
Labeler: Blenheim Pharmacal, Inc.
Application: ANDA074223
Marketing category: ANDA
Marketing start: 2012-01-18
Marketing end: 0000-00-00
Substance: GLIPIZIDE
Active strength: 5 mg/1
Pharmacologic classes: Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	10544-193		I	Inactivated by FDA		2026-08-07
excluded package	package	10544-193	10544-193-60	I	Inactivated by FDA		2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10544-193-60	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10544-193-60	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10544-193-60	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10544-193-60	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10544-193-60	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10544-193-60	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10544-193-60	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10544-193-60	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10544-193-60	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10544-193-60	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10544-193-60	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10544-193-60	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	10544-193-60	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	10544-193-60	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	10544-193-60	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	10544-193-60	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	10544-193-60	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	10544-193-60	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	10544-193-60	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	10544-193-60	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	10544-193-60	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	10544-193-60	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A074223-001	GLIPIZIDE	GLIPIZIDE	5MG	TABLET / ORAL	AB		1995-02-27
A074223-002	GLIPIZIDE	GLIPIZIDE	10MG	TABLET / ORAL	AB		1995-02-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A074223-001	AB
A074223-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A074223-001	GLIPIZIDE	5MG	TABLET / ORAL	AB	1995-02-27	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A074223-002	GLIPIZIDE	10MG	TABLET / ORAL	AB	1995-02-27	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A074223-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074223-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074223-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074223-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074223-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074223-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074223-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074223-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074223-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074223-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074223-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074223-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074223-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074223-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074223-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074223-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074223-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074223-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074223-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074223-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074223-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074223-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074223-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074223-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074223-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074223-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A074223-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A074223-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074223-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A074223-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A074223-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A074223-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A074223-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A074223-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A074223-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A074223-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A074223-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A074223-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A074223-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A074223-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ec4adfb0-aabc-95b9-ad07-5cb8f8533a09	Product name	2	20250625
b1de1ca9-d9db-4f4b-2103-09e2014d30d5	Product name	5	20180912
2dee091b-3b8c-d27a-b1ba-fcb0d32e776a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
10544-193-60	2020-01-31	C162847	48780-1	9d75b9d0-0253-f424-e053-dadaa90a57ce	Glipizide Tablets USP Revised: November 2008 Rx only 174347

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10544-193-60	Glipizide	60 in 1 BOTTLE	TABLET	60		3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GLIPIZIDE	ACTIVE INGREDIENT	X7WDT95N5C	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3
GLIPIZIDE	ACTIVE MOIETY	X7WDT95N5C	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10544-193	GLIPIZIDE TABLET [BLENHEIM PHARMACAL, INC.]	3	Legacy NDC, 1 package rows	20150323_3030da52-4e59-44d0-9d62-4b27e38e7e91.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glipizide	GLIPIZIDE	Preferred Pharmaceuticals Inc..	02857195-33e9-4c1f-9e5f-7cc62f283649	2026-05-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	Preferred Pharmaceuticals Inc.	65ddb8b3-19d4-482f-8aec-49dc167a4c40	2026-05-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	A-S Medication Solutions	99af53db-e102-427a-a5a2-be1e69b3152d	2026-04-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	Northwind Health Company, LLC	3bb3b80a-30e8-62fe-e054-00144ff8d46c	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	PD-Rx Pharmaceuticals, Inc.	c829b7bf-1a12-44b2-b5ce-fd44a1f0d333	2025-10-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	Proficient Rx LP	d5398166-5698-4ee5-bd41-3c24e4445b53	2025-10-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	NuCare Pharmaceuticals,Inc.	5c627a52-e4ca-7103-e053-2a91aa0ae13f	2025-08-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	A-S Medication Solutions	b31ab6dd-0277-43ee-a054-f20c462f0c56	2025-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	Bryant Ranch Prepack	afb65cc1-a4fb-4771-b09c-dcf6e8c5786e	2024-08-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	NuCare Pharmaceuticals,Inc.	589dc76d-c347-0589-e053-2991aa0a2520	2024-07-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	NuCare Pharmaceuticals,Inc.	8c27962d-626b-30e6-e053-2a95a90a49c6	2024-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	NuCare Pharmaceuticals,Inc.	7c21db4d-6b9b-36c3-e053-2991aa0a0fd9	2024-06-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	Actavis Pharma, Inc.	ad55dfd7-ffb5-478a-aa84-1009fa921e22	2023-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	A-S Medication Solutions	0874340a-75a1-4ac9-b224-80c5c24e1b41	2023-12-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	NCS HealthCare of KY, LLC dba Vangard Labs	bf5ff427-3ee4-4064-a55e-35daa2f12a06	2023-02-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223
Glipizide	GLIPIZIDE	Aphena Pharma Solutions - Tennessee, LLC	d6c016f7-bf93-4322-a179-d4798234b381	2017-08-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074223 application number: ANDA074223

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X7WDT95N5C	GLIPIZIDE	29094-61-9	GLIPIZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310488	glipiZIDE 10 MG Oral Tablet	PSN	3030da52-4e59-44d0-9d62-4b27e38e7e91	3
310490	glipiZIDE 5 MG Oral Tablet	PSN	3030da52-4e59-44d0-9d62-4b27e38e7e91	3
310488	glipizide 10 MG Oral Tablet	SCD	3030da52-4e59-44d0-9d62-4b27e38e7e91	3
310490	glipizide 5 MG Oral Tablet	SCD	3030da52-4e59-44d0-9d62-4b27e38e7e91	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
10544-193-60	10544019360	60 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Glipizide Tablets USP Revised: November 2008 Rx only 174347	Blenheim Pharmacal, Inc.	2015-03-23	HUMAN PRESCRIPTION DRUG LABEL	3